191 related articles for article (PubMed ID: 35624470)
1. Possible role of negative human papillomavirus E6/E7 mRNA as a predictor of regression of cervical intraepithelial neoplasia 2 lesions in hr-HPV positive women.
Bruno MT; Cassaro N; Vitale SG; Guaita A; Boemi S
Virol J; 2022 May; 19(1):95. PubMed ID: 35624470
[TBL] [Abstract][Full Text] [Related]
2. p16/ki67 and E6/E7 mRNA Accuracy and Prognostic Value in Triaging HPV DNA-Positive Women.
Giorgi Rossi P; Carozzi F; Ronco G; Allia E; Bisanzi S; Gillio-Tos A; De Marco L; Rizzolo R; Gustinucci D; Del Mistro A; Frayle H; Confortini M; Iossa A; Cesarini E; Bulletti S; Passamonti B; Gori S; Toniolo L; Barca A; Bonvicini L; Mancuso P; Venturelli F; Benevolo M;
J Natl Cancer Inst; 2021 Mar; 113(3):292-300. PubMed ID: 32745170
[TBL] [Abstract][Full Text] [Related]
3. [The value of P16/ki67 double labeling, HPV E6/E7 mRNA detection and their combined application in cytological shunt diagnosis of low-grade squamous intraepithelial lesions].
Guan Y; Peng J; Yuan C; Mi X; Chen Z; Chen J; Chen A; Liu J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Jan; 36(1):63-68. PubMed ID: 32314725
[TBL] [Abstract][Full Text] [Related]
4. Analysis of factors affecting the prognosis of patients with cervical intraepithelial neoplasia 2.
Zhang X; Xu Y; Meng T; Shen D
Oncol Lett; 2020 Aug; 20(2):1810-1816. PubMed ID: 32724424
[TBL] [Abstract][Full Text] [Related]
5. A prospective study of women with ASCUS or LSIL pap smears at baseline and HPV E6/E7 mRNA positive: a 3-year follow-up.
Bruno MT; Ferrara M; Fava V; Barrasso G; Panella MM
Epidemiol Infect; 2018 Apr; 146(5):612-618. PubMed ID: 29465024
[TBL] [Abstract][Full Text] [Related]
6. Accuracy of HPV E6/E7 mRNA examination using in situ hybridization in diagnosing cervical intraepithelial lesions.
Hui C; Bai H; Liu J; Lu X; Wang S; Zhang Z; Jin M; Wang Y; Liu Y
Diagn Pathol; 2021 Feb; 16(1):13. PubMed ID: 33608003
[TBL] [Abstract][Full Text] [Related]
7. Role of p16(INK4a) cytology testing as an adjunct to enhance the diagnostic specificity and accuracy in human papillomavirus-positive women within an organized cervical cancer screening program.
Gustinucci D; Passamonti B; Cesarini E; Butera D; Palmieri EA; Bulletti S; Carlani A; Staiano M; D'Amico MR; D'Angelo V; Di Dato E; Martinelli N; Malaspina M; Spita N; Tintori B; Fulciniti F
Acta Cytol; 2012; 56(5):506-14. PubMed ID: 23075891
[TBL] [Abstract][Full Text] [Related]
8. [HPV E6 and E7 mRNA combined with HPV 16 and 18 or 45 genotyping testing as a means of cervical cancer opportunistic screening].
Wang JJ; Dong J; Deng ZX; Wang PF; Zhang XX; Du Y
Zhonghua Fu Chan Ke Za Zhi; 2019 May; 54(5):301-306. PubMed ID: 31154710
[No Abstract] [Full Text] [Related]
9. p16 Immunohistochemistry is useful in confirming high-grade squamous intraepithelial lesions (HSIL) in women with negative HPV testing.
Zhang G; Yang B; Abdul-Karim FW
Int J Gynecol Pathol; 2015 Mar; 34(2):180-6. PubMed ID: 25675189
[TBL] [Abstract][Full Text] [Related]
10. High-risk human papillomavirus E6/E7 mRNA and L1 DNA as markers of residual/recurrent cervical intraepithelial neoplasia.
Persson M; Brismar Wendel S; Ljungblad L; Johansson B; Weiderpass E; Andersson S
Oncol Rep; 2012 Jul; 28(1):346-52. PubMed ID: 22484610
[TBL] [Abstract][Full Text] [Related]
11. HPV genotype determination and E6/E7 mRNA detection for management of HPV positive women.
Bruno MT; Ferrara M; Fava V; Rapisarda A; Coco A
Virol J; 2018 Mar; 15(1):52. PubMed ID: 29587778
[TBL] [Abstract][Full Text] [Related]
12. Separate analysis of human papillomavirus E6 and E7 messenger RNAs to predict cervical neoplasia progression.
Liu S; Minaguchi T; Lachkar B; Zhang S; Xu C; Tenjimbayashi Y; Shikama A; Tasaka N; Akiyama A; Sakurai M; Nakao S; Ochi H; Onuki M; Matsumoto K; Yoshikawa H; Satoh T
PLoS One; 2018; 13(2):e0193061. PubMed ID: 29466435
[TBL] [Abstract][Full Text] [Related]
13. Sensitivity and specificity values of high-risk HPV DNA, p16/ki-67 and HPV mRNA in young women with atypical squamous cells of undetermined significance (ASCUS) or low-grade squamous intraepithelial lesion (LSIL).
Frega A; Pavone M; Sesti F; Leone C; Bianchi P; Cozza G; Colombrino C; Lukic A; Marziani R; De Sanctis L; Delli Carpini G; Caserta D; Ciavattini A
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10672-10677. PubMed ID: 31858534
[TBL] [Abstract][Full Text] [Related]
14. [Clinical effect evaluation of high risk human papilloma virus E6/E7 mRNA in triaging women with atypical squamous cells of undetermined significance].
Guo Z; Zhao DM; Zhang SK; Wu ZN; Sun XB; Jia MM; Chen Q; Guo LW; Chen PP; Zhang JG
Zhonghua Zhong Liu Za Zhi; 2021 Oct; 43(10):1094-1099. PubMed ID: 34695901
[No Abstract] [Full Text] [Related]
15. Immunostaining of p16(INK4a)/Ki-67 and L1 capsid protein on liquid-based cytology specimens obtained from ASC-H and LSIL-H cases.
Byun SW; Lee A; Kim S; Choi YJ; Lee YS; Park JS
Int J Med Sci; 2013; 10(12):1602-7. PubMed ID: 24151431
[TBL] [Abstract][Full Text] [Related]
16. [The role of HPV E6/E7 mRNA combined with P16/ki67 immunocytochemistry in the diagnosis of atypical squamous cells of undetermined significance(ASCUS)].
Zhan X; Wang S; Wu X; Qiu X; Li F; Zeng Y; Chen Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Oct; 34(10):937-941. PubMed ID: 30554588
[TBL] [Abstract][Full Text] [Related]
17. Performance of p16/Ki67 immunostaining, HPV E6/E7 mRNA testing, and HPV DNA assay to detect high-grade cervical dysplasia in women with ASCUS.
Zhu Y; Ren C; Yang L; Zhang X; Liu L; Wang Z
BMC Cancer; 2019 Mar; 19(1):271. PubMed ID: 30917784
[TBL] [Abstract][Full Text] [Related]
18. [Assessment of the diagnostic value and prognosis of different detection markers in endocervical adenocarcinoma].
Zhang CN; Liu XY; Li Q; Song YZ; Liu B; Yin J; Yang JH; Zhong L; Sun L; Zhang X; Chen W
Zhonghua Zhong Liu Za Zhi; 2023 May; 45(5):402-409. PubMed ID: 37188625
[No Abstract] [Full Text] [Related]
19. The value of HPV E6/E7 mRNA quantitative analysis in distinguishing high-grade cervical squamous intraepithelial lesions from low-grade cervical squamous intraepithelial lesions.
Liu J; Yang T; Hu Y; Ye C
J Virol Methods; 2021 Mar; 289():114014. PubMed ID: 33188806
[TBL] [Abstract][Full Text] [Related]
20. Clinical Value of Human Papillomavirus E6/E7 mRNA Detection in Screening for Cervical Cancer in Women Positive for Human Papillomavirus DNA or.
Han L; Husaiyin S; Zhao F; Rezhake R; Niyazi M
Clin Lab; 2018 Sep; 64(9):1363-1371. PubMed ID: 30274003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]